

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 4.78305247 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 4.46374748 |
| 3 | glycolipid catabolic process (GO:0019377) | 4.35662025 |
| 4 | response to peptidoglycan (GO:0032494) | 4.12540984 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.03925919 |
| 6 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.92496993 |
| 7 | vitamin transmembrane transport (GO:0035461) | 3.90255506 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 3.82250985 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 3.82250985 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.82250985 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.82250985 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.82250985 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 3.82250985 |
| 14 | folic acid transport (GO:0015884) | 3.76391409 |
| 15 | ceramide catabolic process (GO:0046514) | 3.71504378 |
| 16 | purine nucleobase biosynthetic process (GO:0009113) | 3.69995980 |
| 17 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.66249659 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 3.65127793 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 3.57377612 |
| 20 | regulation of RIG-I signaling pathway (GO:0039535) | 3.57018307 |
| 21 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55432064 |
| 22 | T-helper 1 type immune response (GO:0042088) | 3.54286070 |
| 23 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.51677443 |
| 24 | positive regulation of interferon-beta production (GO:0032728) | 3.49188735 |
| 25 | low-density lipoprotein particle clearance (GO:0034383) | 3.48823186 |
| 26 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.45468270 |
| 27 | folic acid metabolic process (GO:0046655) | 3.41707315 |
| 28 | response to thyroid hormone (GO:0097066) | 3.36151779 |
| 29 | positive regulation of interferon-alpha production (GO:0032727) | 3.35991837 |
| 30 | detection of external biotic stimulus (GO:0098581) | 3.35846763 |
| 31 | detection of other organism (GO:0098543) | 3.35703873 |
| 32 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.27420404 |
| 33 | negative regulation of lipid storage (GO:0010888) | 3.26613202 |
| 34 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.22072518 |
| 35 | regulation of interferon-alpha production (GO:0032647) | 3.20308847 |
| 36 | ribosome assembly (GO:0042255) | 3.20090353 |
| 37 | membrane lipid catabolic process (GO:0046466) | 3.20024777 |
| 38 | regulation of chemokine biosynthetic process (GO:0045073) | 3.18195097 |
| 39 | sphingolipid catabolic process (GO:0030149) | 3.14409449 |
| 40 | superoxide anion generation (GO:0042554) | 3.13435409 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.12634661 |
| 42 | regulation of podosome assembly (GO:0071801) | 3.10643791 |
| 43 | mitotic metaphase plate congression (GO:0007080) | 3.07947258 |
| 44 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.05759920 |
| 45 | natural killer cell mediated immunity (GO:0002228) | 3.05759920 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 3.05009779 |
| 47 | detection of bacterium (GO:0016045) | 3.04873921 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.04238414 |
| 49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.04238414 |
| 50 | cellular extravasation (GO:0045123) | 3.03091338 |
| 51 | N-acetylneuraminate metabolic process (GO:0006054) | 3.02909333 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02662593 |
| 53 | respiratory burst (GO:0045730) | 3.02515516 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01687813 |
| 55 | reactive oxygen species biosynthetic process (GO:1903409) | 3.01468472 |
| 56 | skeletal muscle tissue regeneration (GO:0043403) | 3.01168040 |
| 57 | regulation of superoxide anion generation (GO:0032928) | 3.01057192 |
| 58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00351213 |
| 59 | regulation of macrophage chemotaxis (GO:0010758) | 2.99794890 |
| 60 | detection of biotic stimulus (GO:0009595) | 2.99493823 |
| 61 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.98010245 |
| 62 | positive regulation of leukocyte degranulation (GO:0043302) | 2.96694888 |
| 63 | regulation of interferon-beta production (GO:0032648) | 2.96617346 |
| 64 | regulation of leukocyte degranulation (GO:0043300) | 2.93885641 |
| 65 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.93294760 |
| 66 | pinocytosis (GO:0006907) | 2.90092739 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 2.89835358 |
| 68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88082534 |
| 69 | amyloid precursor protein catabolic process (GO:0042987) | 2.88014290 |
| 70 | amino sugar catabolic process (GO:0046348) | 2.87915470 |
| 71 | intestinal epithelial cell development (GO:0060576) | 2.86281446 |
| 72 | macrophage activation (GO:0042116) | 2.85263094 |
| 73 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.83131081 |
| 74 | positive regulation of antigen processing and presentation (GO:0002579) | 2.82179738 |
| 75 | regulation of mononuclear cell migration (GO:0071675) | 2.81949322 |
| 76 | peptide catabolic process (GO:0043171) | 2.81925295 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81388701 |
| 78 | regulation of vitamin metabolic process (GO:0030656) | 2.80761077 |
| 79 | nucleobase biosynthetic process (GO:0046112) | 2.80265383 |
| 80 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79497294 |
| 81 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.79356656 |
| 82 | regulation of response to interferon-gamma (GO:0060330) | 2.79225095 |
| 83 | cellular response to arsenic-containing substance (GO:0071243) | 2.79115213 |
| 84 | protein localization to endosome (GO:0036010) | 2.77482912 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 2.76612141 |
| 86 | germinal center formation (GO:0002467) | 2.76341776 |
| 87 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.75999366 |
| 88 | positive regulation of cholesterol efflux (GO:0010875) | 2.75916296 |
| 89 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.72303587 |
| 90 | barbed-end actin filament capping (GO:0051016) | 2.72137430 |
| 91 | granulocyte activation (GO:0036230) | 2.70728372 |
| 92 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.70659597 |
| 93 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.70467990 |
| 94 | leukocyte mediated cytotoxicity (GO:0001909) | 2.69103409 |
| 95 | interferon-gamma secretion (GO:0072643) | 2.68859331 |
| 96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68587008 |
| 97 | myeloid dendritic cell activation (GO:0001773) | 2.68561942 |
| 98 | monocyte chemotaxis (GO:0002548) | 2.68377425 |
| 99 | positive regulation of heat generation (GO:0031652) | 2.67387489 |
| 100 | eosinophil chemotaxis (GO:0048245) | 2.67050560 |
| 101 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.66965421 |
| 102 | response to muramyl dipeptide (GO:0032495) | 2.66849311 |
| 103 | modified amino acid transport (GO:0072337) | 2.66025204 |
| 104 | regulation of fever generation (GO:0031620) | 2.65630029 |
| 105 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.64906371 |
| 106 | type I interferon signaling pathway (GO:0060337) | 2.64413773 |
| 107 | cellular response to type I interferon (GO:0071357) | 2.64413773 |
| 108 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.63932567 |
| 109 | positive regulation of mast cell degranulation (GO:0043306) | 2.63360681 |
| 110 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.63360681 |
| 111 | response to host immune response (GO:0052572) | 2.63272066 |
| 112 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.63272066 |
| 113 | cellular response to lipopolysaccharide (GO:0071222) | 2.61602924 |
| 114 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.60861075 |
| 115 | response to type I interferon (GO:0034340) | 2.59879256 |
| 116 | plasma lipoprotein particle clearance (GO:0034381) | 2.59523488 |
| 117 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59501986 |
| 118 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.59469448 |
| 119 | termination of RNA polymerase III transcription (GO:0006386) | 2.59469448 |
| 120 | B cell mediated immunity (GO:0019724) | 2.59092283 |
| 121 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.58670560 |
| 122 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.58377848 |
| 123 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.58066113 |
| 124 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.58047320 |
| 125 | response to interferon-gamma (GO:0034341) | 2.55490528 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55102290 |
| 127 | cellular response to molecule of bacterial origin (GO:0071219) | 2.54972247 |
| 128 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.54337206 |
| 129 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.54329444 |
| 130 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.53235024 |
| 131 | response to protozoan (GO:0001562) | 2.52712318 |
| 132 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.52534331 |
| 133 | cellular response to virus (GO:0098586) | 2.51547493 |
| 134 | negative regulation by host of viral transcription (GO:0043922) | 2.51198887 |
| 135 | regulation of spindle organization (GO:0090224) | 2.50752710 |
| 136 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.50122277 |
| 137 | adhesion of symbiont to host (GO:0044406) | 2.49776885 |
| 138 | positive regulation of mast cell activation (GO:0033005) | 2.48976911 |
| 139 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.48184981 |
| 140 | negative regulation of cell killing (GO:0031342) | 2.48184981 |
| 141 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.47116267 |
| 142 | cytokine secretion (GO:0050663) | 2.47095713 |
| 143 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44630970 |
| 144 | regulation of cholesterol storage (GO:0010885) | 2.43073502 |
| 145 | regulation of antigen processing and presentation (GO:0002577) | 2.40846971 |
| 146 | vitamin transport (GO:0051180) | 2.39246197 |
| 147 | DNA deamination (GO:0045006) | 2.38525960 |
| 148 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.37695988 |
| 149 | S-adenosylmethionine metabolic process (GO:0046500) | 2.37079917 |
| 150 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.36654972 |
| 151 | detection of molecule of bacterial origin (GO:0032490) | 2.35985708 |
| 152 | positive regulation of T cell apoptotic process (GO:0070234) | 2.35470604 |
| 153 | pantothenate metabolic process (GO:0015939) | 2.34432313 |
| 154 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.33659652 |
| 155 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.32069955 |
| 156 | neutrophil activation (GO:0042119) | 2.31589198 |
| 157 | urate metabolic process (GO:0046415) | 2.30958829 |
| 158 | ribosome biogenesis (GO:0042254) | 2.30855822 |
| 159 | response to xenobiotic stimulus (GO:0009410) | 2.30324292 |
| 160 | myeloid dendritic cell differentiation (GO:0043011) | 2.29778355 |
| 161 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.29343476 |
| 162 | positive regulation of chemokine production (GO:0032722) | 2.29184485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.34863833 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.05382622 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.18490149 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63782154 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52972012 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47699742 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.46387838 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44062729 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.38865649 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36540357 |
| 11 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.31727229 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26171141 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.23290864 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.22811777 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19125931 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15331088 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.09900690 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.06325150 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.02759007 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.97637160 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.93599830 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.90787482 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90458841 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.88060902 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87824488 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.86535571 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84242959 |
| 28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80170223 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.78776518 |
| 30 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.75727934 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74434620 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68735410 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67943776 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66169975 |
| 35 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.64992715 |
| 36 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.64456246 |
| 37 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62804629 |
| 38 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.62025553 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.60214371 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.58404269 |
| 41 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57208109 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56495140 |
| 43 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56326369 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.55598738 |
| 45 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50342984 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.50318232 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48583888 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47251071 |
| 49 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46516210 |
| 50 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.46403005 |
| 51 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45352835 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44910809 |
| 53 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43413498 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42615367 |
| 55 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.41512914 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41185639 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40755844 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39074552 |
| 59 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.38320466 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36987176 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.36713943 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36177178 |
| 63 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35867712 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35706255 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33847495 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33752110 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33273617 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.31806670 |
| 69 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31069160 |
| 70 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27564037 |
| 71 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.27440046 |
| 72 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.25493101 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24941134 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24275070 |
| 75 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24004254 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23482268 |
| 77 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.23420576 |
| 78 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22885579 |
| 79 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22859277 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22583236 |
| 81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22482406 |
| 82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21194120 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20762962 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19714748 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19504429 |
| 86 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18774878 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18029611 |
| 88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.16690168 |
| 89 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15095716 |
| 90 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14651208 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14576602 |
| 92 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13891703 |
| 93 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13698600 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13419527 |
| 95 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13257366 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12382987 |
| 97 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11877782 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11551873 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09301216 |
| 100 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09094607 |
| 101 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09034286 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08940844 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08501768 |
| 104 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07123103 |
| 105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06962459 |
| 106 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06618086 |
| 107 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06102662 |
| 108 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05738478 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05302295 |
| 110 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04757820 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04444802 |
| 112 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04020774 |
| 113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03943608 |
| 114 | MYB_26560356_Chip-Seq_TH1_Human | 1.03600186 |
| 115 | MYB_26560356_Chip-Seq_TH2_Human | 1.02463233 |
| 116 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02379174 |
| 117 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01382290 |
| 118 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.00764750 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00702145 |
| 120 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99606436 |
| 121 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98794688 |
| 122 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98565611 |
| 123 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98517379 |
| 124 | MAF_26560356_Chip-Seq_TH1_Human | 0.98282728 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97712352 |
| 126 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.96998772 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96272648 |
| 128 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96141074 |
| 129 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95974322 |
| 130 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95545296 |
| 131 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.94117483 |
| 132 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94089710 |
| 133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93947318 |
| 134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93739916 |
| 135 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93200478 |
| 136 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91733706 |
| 137 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91526740 |
| 138 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.89073022 |
| 139 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88564723 |
| 140 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87979266 |
| 141 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87716245 |
| 142 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.87227942 |
| 143 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86959365 |
| 144 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86766771 |
| 145 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.86529197 |
| 146 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.85509119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 3.66355776 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.11465569 |
| 3 | MP0003436_decreased_susceptibility_to | 3.06384421 |
| 4 | MP0009785_altered_susceptibility_to | 2.99334526 |
| 5 | MP0003693_abnormal_embryo_hatching | 2.77556418 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.69868758 |
| 7 | MP0003724_increased_susceptibility_to | 2.68054276 |
| 8 | MP0008260_abnormal_autophagy | 2.60239107 |
| 9 | MP0006082_CNS_inflammation | 2.55420977 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.54813735 |
| 11 | MP0003303_peritoneal_inflammation | 2.52852559 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.37458106 |
| 13 | MP0005451_abnormal_body_composition | 2.33071450 |
| 14 | MP0002419_abnormal_innate_immunity | 2.32867230 |
| 15 | MP0005025_abnormal_response_to | 2.23150245 |
| 16 | MP0005671_abnormal_response_to | 2.22609303 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.22513385 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.12933127 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.00621138 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.98839960 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.90316194 |
| 22 | MP0002723_abnormal_immune_serum | 1.87196347 |
| 23 | MP0003718_maternal_effect | 1.85104068 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.84024477 |
| 25 | MP0001790_abnormal_immune_system | 1.80854843 |
| 26 | MP0005387_immune_system_phenotype | 1.80854843 |
| 27 | MP0009278_abnormal_bone_marrow | 1.79494915 |
| 28 | MP0003828_pulmonary_edema | 1.74933709 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.72000839 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.72000839 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.71423242 |
| 32 | MP0003186_abnormal_redox_activity | 1.70100954 |
| 33 | MP0005365_abnormal_bile_salt | 1.69761184 |
| 34 | MP0000685_abnormal_immune_system | 1.69587630 |
| 35 | MP0001800_abnormal_humoral_immune | 1.69489367 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.68444406 |
| 37 | MP0002254_reproductive_system_inflammat | 1.67675349 |
| 38 | MP0003448_altered_tumor_morphology | 1.65785036 |
| 39 | MP0008004_abnormal_stomach_pH | 1.65708695 |
| 40 | MP0001853_heart_inflammation | 1.61511518 |
| 41 | MP0008469_abnormal_protein_level | 1.61178231 |
| 42 | MP0004947_skin_inflammation | 1.60853452 |
| 43 | MP0009764_decreased_sensitivity_to | 1.60717724 |
| 44 | MP0004510_myositis | 1.60551644 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.60362038 |
| 46 | MP0003646_muscle_fatigue | 1.59510275 |
| 47 | MP0001819_abnormal_immune_cell | 1.56609335 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.52499653 |
| 49 | MP0003111_abnormal_nucleus_morphology | 1.52016494 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.44072512 |
| 51 | MP0010307_abnormal_tumor_latency | 1.40358366 |
| 52 | MP0002405_respiratory_system_inflammati | 1.40126630 |
| 53 | MP0005310_abnormal_salivary_gland | 1.39457558 |
| 54 | MP0000343_altered_response_to | 1.39439760 |
| 55 | MP0004019_abnormal_vitamin_homeostasis | 1.38803616 |
| 56 | MP0003690_abnormal_glial_cell | 1.37633200 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.34635380 |
| 58 | MP0003329_amyloid_beta_deposits | 1.33443601 |
| 59 | MP0000858_altered_metastatic_potential | 1.32620207 |
| 60 | MP0003195_calcinosis | 1.32066103 |
| 61 | MP0000716_abnormal_immune_system | 1.21641221 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.21027342 |
| 63 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16481530 |
| 64 | MP0003077_abnormal_cell_cycle | 1.16042342 |
| 65 | MP0002006_tumorigenesis | 1.14898210 |
| 66 | MP0004957_abnormal_blastocyst_morpholog | 1.12455969 |
| 67 | MP0002398_abnormal_bone_marrow | 1.08562194 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.08508575 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.08461801 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.04873439 |
| 71 | MP0001542_abnormal_bone_strength | 1.02575700 |
| 72 | MP0002429_abnormal_blood_cell | 1.02191863 |
| 73 | MP0002722_abnormal_immune_system | 1.01348851 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.00782590 |
| 75 | MP0002132_abnormal_respiratory_system | 1.00601451 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.99023612 |
| 77 | MP0005332_abnormal_amino_acid | 0.98735736 |
| 78 | MP0000609_abnormal_liver_physiology | 0.96800421 |
| 79 | MP0001756_abnormal_urination | 0.96565945 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.95467969 |
| 81 | MP0002163_abnormal_gland_morphology | 0.95365132 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.93317659 |
| 83 | MP0009643_abnormal_urine_homeostasis | 0.93099924 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.92995945 |
| 85 | MP0005166_decreased_susceptibility_to | 0.92166046 |
| 86 | MP0005395_other_phenotype | 0.91732428 |
| 87 | MP0000490_abnormal_crypts_of | 0.88807682 |
| 88 | MP0005085_abnormal_gallbladder_physiolo | 0.87689145 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.87623332 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.87578914 |
| 91 | MP0005165_increased_susceptibility_to | 0.87513116 |
| 92 | MP0009763_increased_sensitivity_to | 0.87295696 |
| 93 | MP0000750_abnormal_muscle_regeneration | 0.85954926 |
| 94 | MP0004883_abnormal_blood_vessel | 0.85946869 |
| 95 | MP0002139_abnormal_hepatobiliary_system | 0.85668769 |
| 96 | MP0003091_abnormal_cell_migration | 0.84415537 |
| 97 | MP0000604_amyloidosis | 0.84301304 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.84020744 |
| 99 | MP0008007_abnormal_cellular_replicative | 0.83564539 |
| 100 | MP0003075_altered_response_to | 0.83091964 |
| 101 | MP0002998_abnormal_bone_remodeling | 0.82303725 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.81560953 |
| 103 | MP0005647_abnormal_sex_gland | 0.81552581 |
| 104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.81149932 |
| 105 | MP0005390_skeleton_phenotype | 0.80823524 |
| 106 | MP0006054_spinal_hemorrhage | 0.79764014 |
| 107 | MP0000920_abnormal_myelination | 0.79327664 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.78281397 |
| 109 | MP0003795_abnormal_bone_structure | 0.76546354 |
| 110 | MP0002166_altered_tumor_susceptibility | 0.76421891 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76111838 |
| 112 | MP0005164_abnormal_response_to | 0.75765674 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.75654828 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.74597831 |
| 115 | MP0003879_abnormal_hair_cell | 0.74137766 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.73061679 |
| 117 | MP0005257_abnormal_intraocular_pressure | 0.72828105 |
| 118 | MP0000627_abnormal_mammary_gland | 0.72749289 |
| 119 | MP0001851_eye_inflammation | 0.72088345 |
| 120 | MP0002396_abnormal_hematopoietic_system | 0.71726596 |
| 121 | MP0001663_abnormal_digestive_system | 0.70629152 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.70444334 |
| 123 | MP0001764_abnormal_homeostasis | 0.70317329 |
| 124 | MP0000249_abnormal_blood_vessel | 0.69546202 |
| 125 | MP0000598_abnormal_liver_morphology | 0.69435820 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.69360047 |
| 127 | MP0001873_stomach_inflammation | 0.68794063 |
| 128 | MP0005334_abnormal_fat_pad | 0.68157604 |
| 129 | MP0001849_ear_inflammation | 0.68055566 |
| 130 | MP0008058_abnormal_DNA_repair | 0.67866923 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.66801805 |
| 132 | MP0005360_urolithiasis | 0.66279903 |
| 133 | MP0003786_premature_aging | 0.65618639 |
| 134 | MP0010094_abnormal_chromosome_stability | 0.62670801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.21530713 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.94224246 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.93496953 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.62787516 |
| 5 | Loss of speech (HP:0002371) | 4.45805800 |
| 6 | Pustule (HP:0200039) | 4.41061292 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.41034041 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 3.53643588 |
| 9 | Nausea (HP:0002018) | 3.45404435 |
| 10 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.44310317 |
| 11 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.44310317 |
| 12 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.44310317 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 3.42032049 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.39391610 |
| 15 | Gout (HP:0001997) | 3.32673491 |
| 16 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.31526777 |
| 17 | Mucopolysacchariduria (HP:0008155) | 3.31526777 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27640171 |
| 19 | Prolonged neonatal jaundice (HP:0006579) | 3.27483471 |
| 20 | Hyperglycinuria (HP:0003108) | 3.18510558 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.14461870 |
| 22 | Complement deficiency (HP:0004431) | 3.12341340 |
| 23 | Multiple enchondromatosis (HP:0005701) | 3.08955879 |
| 24 | Hyperglycinemia (HP:0002154) | 3.01992924 |
| 25 | Myositis (HP:0100614) | 3.01085671 |
| 26 | Gingivitis (HP:0000230) | 2.96913009 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.96161710 |
| 28 | Osteolytic defects of the hand bones (HP:0009699) | 2.96161710 |
| 29 | Obstructive lung disease (HP:0006536) | 2.94873349 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.94873349 |
| 31 | Purpura (HP:0000979) | 2.92488436 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.91827852 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.91827852 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 2.91827852 |
| 35 | Stomatitis (HP:0010280) | 2.89206469 |
| 36 | Thick nail (HP:0001805) | 2.84097458 |
| 37 | Orchitis (HP:0100796) | 2.83749354 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.81472393 |
| 39 | Abnormality of complement system (HP:0005339) | 2.81237637 |
| 40 | Amyloidosis (HP:0011034) | 2.80025928 |
| 41 | Mutism (HP:0002300) | 2.77368996 |
| 42 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.77287071 |
| 43 | Axonal loss (HP:0003447) | 2.77206388 |
| 44 | Malnutrition (HP:0004395) | 2.72430437 |
| 45 | Nuclear cataract (HP:0100018) | 2.72250426 |
| 46 | Recurrent skin infections (HP:0001581) | 2.67320626 |
| 47 | Birth length less than 3rd percentile (HP:0003561) | 2.66020746 |
| 48 | Breast hypoplasia (HP:0003187) | 2.65620396 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.65188835 |
| 50 | Optic neuritis (HP:0100653) | 2.65188835 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.60541690 |
| 52 | Basal ganglia calcification (HP:0002135) | 2.60366086 |
| 53 | Recurrent fungal infections (HP:0002841) | 2.59294851 |
| 54 | Anorexia (HP:0002039) | 2.51554914 |
| 55 | Myocardial infarction (HP:0001658) | 2.51428039 |
| 56 | Increased IgM level (HP:0003496) | 2.47496767 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.46630661 |
| 58 | Apathy (HP:0000741) | 2.45599095 |
| 59 | Diminished motivation (HP:0000745) | 2.45462699 |
| 60 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.45109943 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.43950798 |
| 62 | Progressive neurologic deterioration (HP:0002344) | 2.43806947 |
| 63 | Cerebral inclusion bodies (HP:0100314) | 2.43526048 |
| 64 | Polycythemia (HP:0001901) | 2.41500154 |
| 65 | Xanthomatosis (HP:0000991) | 2.40739234 |
| 66 | Prostate neoplasm (HP:0100787) | 2.38940665 |
| 67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.38146254 |
| 68 | Entropion (HP:0000621) | 2.37623990 |
| 69 | Petechiae (HP:0000967) | 2.36691762 |
| 70 | Atrioventricular block (HP:0001678) | 2.34400984 |
| 71 | Glomerulonephritis (HP:0000099) | 2.33154706 |
| 72 | Vasculitis (HP:0002633) | 2.32413720 |
| 73 | Upper motor neuron abnormality (HP:0002127) | 2.31783426 |
| 74 | Premature loss of primary teeth (HP:0006323) | 2.30655910 |
| 75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.29973935 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 2.29973935 |
| 77 | Carpal bone hypoplasia (HP:0001498) | 2.28333670 |
| 78 | Rough bone trabeculation (HP:0100670) | 2.26350413 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.24745025 |
| 80 | Muscle fiber splitting (HP:0003555) | 2.24151784 |
| 81 | Poor head control (HP:0002421) | 2.24007579 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.21355701 |
| 83 | Pathologic fracture (HP:0002756) | 2.19480133 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.19283665 |
| 85 | Periodontitis (HP:0000704) | 2.18246262 |
| 86 | Chronic otitis media (HP:0000389) | 2.16229503 |
| 87 | Personality changes (HP:0000751) | 2.13750390 |
| 88 | Bone pain (HP:0002653) | 2.10948077 |
| 89 | Bundle branch block (HP:0011710) | 2.09478884 |
| 90 | Cheilitis (HP:0100825) | 2.08505899 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04686762 |
| 92 | Urticaria (HP:0001025) | 2.04620519 |
| 93 | Vertebral compression fractures (HP:0002953) | 2.04411226 |
| 94 | Peripheral demyelination (HP:0011096) | 2.03961304 |
| 95 | Asymmetric septal hypertrophy (HP:0001670) | 2.03282794 |
| 96 | Metaphyseal irregularity (HP:0003025) | 2.03224604 |
| 97 | Leukocytosis (HP:0001974) | 2.02564712 |
| 98 | Azoospermia (HP:0000027) | 2.01075465 |
| 99 | Dementia (HP:0000726) | 1.98623082 |
| 100 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.97913771 |
| 101 | Progressive visual loss (HP:0000529) | 1.97123198 |
| 102 | Abnormality of the periventricular white matter (HP:0002518) | 1.96796719 |
| 103 | Recurrent viral infections (HP:0004429) | 1.96534261 |
| 104 | Tetraparesis (HP:0002273) | 1.94719841 |
| 105 | Death in infancy (HP:0001522) | 1.93596717 |
| 106 | Abnormal trabecular bone morphology (HP:0100671) | 1.93263403 |
| 107 | Nephritis (HP:0000123) | 1.93187974 |
| 108 | Pulmonary infiltrates (HP:0002113) | 1.92204120 |
| 109 | Hepatosplenomegaly (HP:0001433) | 1.91989388 |
| 110 | Abnormal spermatogenesis (HP:0008669) | 1.90569768 |
| 111 | Impulsivity (HP:0100710) | 1.90396062 |
| 112 | Increased serum ferritin (HP:0003281) | 1.89187790 |
| 113 | Abnormality of purine metabolism (HP:0004352) | 1.88381754 |
| 114 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.88196879 |
| 115 | Progressive muscle weakness (HP:0003323) | 1.87848989 |
| 116 | Short nail (HP:0001799) | 1.87610653 |
| 117 | Cardiomegaly (HP:0001640) | 1.87334099 |
| 118 | Conjunctival telangiectasia (HP:0000524) | 1.87141346 |
| 119 | Increased purine levels (HP:0004368) | 1.85064914 |
| 120 | Hyperuricemia (HP:0002149) | 1.85064914 |
| 121 | Arterial thrombosis (HP:0004420) | 1.83942118 |
| 122 | Retinal atrophy (HP:0001105) | 1.83587644 |
| 123 | Cellulitis (HP:0100658) | 1.81977965 |
| 124 | Ureteral duplication (HP:0000073) | 1.81461685 |
| 125 | Abnormality of serum amino acid levels (HP:0003112) | 1.81237858 |
| 126 | Agnosia (HP:0010524) | 1.80322695 |
| 127 | Polyneuropathy (HP:0001271) | 1.79578286 |
| 128 | Disinhibition (HP:0000734) | 1.79423091 |
| 129 | Dysostosis multiplex (HP:0000943) | 1.79194293 |
| 130 | Hypergammaglobulinemia (HP:0010702) | 1.79054524 |
| 131 | IgG deficiency (HP:0004315) | 1.79007516 |
| 132 | Increased CSF protein (HP:0002922) | 1.78391813 |
| 133 | Male infertility (HP:0003251) | 1.77212063 |
| 134 | Hematochezia (HP:0002573) | 1.75983673 |
| 135 | Gingival bleeding (HP:0000225) | 1.75966244 |
| 136 | Ileus (HP:0002595) | 1.75540673 |
| 137 | Meningitis (HP:0001287) | 1.75344580 |
| 138 | Abnormality of eosinophils (HP:0001879) | 1.75300546 |
| 139 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.74972601 |
| 140 | Abnormality of the umbilical cord (HP:0010881) | 1.74960385 |
| 141 | Thoracic kyphosis (HP:0002942) | 1.74560245 |
| 142 | Deep venous thrombosis (HP:0002625) | 1.72858942 |
| 143 | Keratoconjunctivitis sicca (HP:0001097) | 1.71867120 |
| 144 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71444847 |
| 145 | Hemoptysis (HP:0002105) | 1.68557038 |
| 146 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.67555280 |
| 147 | Restrictive lung disease (HP:0002091) | 1.66552984 |
| 148 | Hypertriglyceridemia (HP:0002155) | 1.66393198 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.64208696 |
| 150 | Skin nodule (HP:0200036) | 1.63049365 |
| 151 | Polygenic inheritance (HP:0010982) | 1.61962952 |
| 152 | Colitis (HP:0002583) | 1.60495397 |
| 153 | Splenomegaly (HP:0001744) | 1.59515608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.98950060 |
| 2 | BUB1 | 3.54314904 |
| 3 | NME2 | 3.40907819 |
| 4 | MAP3K14 | 2.89709021 |
| 5 | RIPK4 | 2.79972936 |
| 6 | TBK1 | 2.78699373 |
| 7 | PRPF4B | 2.72588847 |
| 8 | TYK2 | 2.70597149 |
| 9 | TAOK2 | 2.46036064 |
| 10 | PIM2 | 2.44962196 |
| 11 | BLK | 2.43552375 |
| 12 | IRAK4 | 2.24820518 |
| 13 | IKBKB | 2.21769451 |
| 14 | WEE1 | 2.17296179 |
| 15 | RPS6KA4 | 2.16619940 |
| 16 | NEK2 | 2.00049021 |
| 17 | IKBKE | 1.87996937 |
| 18 | PLK4 | 1.87741384 |
| 19 | EPHA2 | 1.80308386 |
| 20 | DDR2 | 1.79687137 |
| 21 | FGR | 1.72463703 |
| 22 | MAP4K1 | 1.65389610 |
| 23 | ABL2 | 1.62333102 |
| 24 | ERN1 | 1.61826000 |
| 25 | MARK3 | 1.56717155 |
| 26 | MAP3K3 | 1.54943248 |
| 27 | ARAF | 1.54839469 |
| 28 | TESK2 | 1.54010529 |
| 29 | RIPK1 | 1.52922987 |
| 30 | AKT3 | 1.51015772 |
| 31 | STK3 | 1.47695174 |
| 32 | EIF2AK2 | 1.47399254 |
| 33 | BRSK2 | 1.45500003 |
| 34 | PBK | 1.43958513 |
| 35 | JAK3 | 1.42669056 |
| 36 | EIF2AK3 | 1.38487484 |
| 37 | CAMK1D | 1.35928815 |
| 38 | PIM1 | 1.35396227 |
| 39 | TXK | 1.34784581 |
| 40 | EIF2AK1 | 1.33703462 |
| 41 | CHUK | 1.32843018 |
| 42 | DYRK3 | 1.32021421 |
| 43 | MAP3K1 | 1.31055444 |
| 44 | STK38L | 1.28802946 |
| 45 | ZAK | 1.26370114 |
| 46 | JAK1 | 1.22816044 |
| 47 | SIK1 | 1.21129178 |
| 48 | ZAP70 | 1.20411454 |
| 49 | TESK1 | 1.19479244 |
| 50 | IRAK2 | 1.17703196 |
| 51 | ACVR1B | 1.16070505 |
| 52 | FGFR4 | 1.08541123 |
| 53 | CDC42BPA | 1.08278877 |
| 54 | NEK9 | 1.07847062 |
| 55 | KIT | 1.07763123 |
| 56 | STK24 | 1.07512750 |
| 57 | STK10 | 1.06619917 |
| 58 | SMG1 | 1.00677504 |
| 59 | BMPR2 | 0.98320129 |
| 60 | MOS | 0.97283396 |
| 61 | PDPK1 | 0.93961633 |
| 62 | MAP2K3 | 0.93751095 |
| 63 | TNK2 | 0.89865990 |
| 64 | MAP3K5 | 0.89838432 |
| 65 | ICK | 0.89762578 |
| 66 | PDK2 | 0.89268782 |
| 67 | STK16 | 0.89249239 |
| 68 | TGFBR2 | 0.86929336 |
| 69 | TAOK3 | 0.82837944 |
| 70 | CSF1R | 0.82636973 |
| 71 | MAP3K11 | 0.79003902 |
| 72 | PLK1 | 0.78440755 |
| 73 | CDK4 | 0.76680593 |
| 74 | JAK2 | 0.76217045 |
| 75 | TTK | 0.74234582 |
| 76 | BRAF | 0.73460045 |
| 77 | CSK | 0.72730827 |
| 78 | EPHB1 | 0.71955604 |
| 79 | KDR | 0.71025591 |
| 80 | RAF1 | 0.69087846 |
| 81 | KSR2 | 0.64452709 |
| 82 | PINK1 | 0.64267448 |
| 83 | MAP3K8 | 0.63969124 |
| 84 | STK4 | 0.63611275 |
| 85 | PRKG2 | 0.63498887 |
| 86 | PAK4 | 0.61469153 |
| 87 | PDK1 | 0.61270766 |
| 88 | BCKDK | 0.60144136 |
| 89 | MAP2K2 | 0.60103704 |
| 90 | AURKB | 0.59398095 |
| 91 | SRPK1 | 0.58428312 |
| 92 | NUAK1 | 0.57625915 |
| 93 | TSSK6 | 0.56905304 |
| 94 | TAOK1 | 0.56350967 |
| 95 | RPS6KC1 | 0.54839366 |
| 96 | RPS6KL1 | 0.54839366 |
| 97 | RPS6KA5 | 0.52998987 |
| 98 | LYN | 0.52574262 |
| 99 | CDK6 | 0.52224806 |
| 100 | PTK6 | 0.51916721 |
| 101 | LMTK2 | 0.51638851 |
| 102 | PAK1 | 0.48784253 |
| 103 | MST4 | 0.48553997 |
| 104 | GRK7 | 0.48247865 |
| 105 | MARK2 | 0.48219460 |
| 106 | PLK3 | 0.48134427 |
| 107 | MAP2K6 | 0.47991926 |
| 108 | CAMK1G | 0.47652178 |
| 109 | IRAK1 | 0.44611056 |
| 110 | BRSK1 | 0.44582335 |
| 111 | PKN2 | 0.44398445 |
| 112 | PRKCD | 0.43920727 |
| 113 | FES | 0.43876789 |
| 114 | PRKD2 | 0.43692243 |
| 115 | RPS6KA2 | 0.43310419 |
| 116 | NLK | 0.42825764 |
| 117 | LRRK2 | 0.42669615 |
| 118 | PDK3 | 0.42625638 |
| 119 | PDK4 | 0.42625638 |
| 120 | LCK | 0.41519127 |
| 121 | MATK | 0.39943553 |
| 122 | TEC | 0.39888167 |
| 123 | SIK3 | 0.39079594 |
| 124 | ABL1 | 0.38932530 |
| 125 | MAP3K13 | 0.38809809 |
| 126 | LATS2 | 0.37950372 |
| 127 | SYK | 0.37379720 |
| 128 | CHEK2 | 0.36308138 |
| 129 | RPS6KA6 | 0.36218707 |
| 130 | HCK | 0.35743490 |
| 131 | GSK3A | 0.35252895 |
| 132 | MAPK11 | 0.34178588 |
| 133 | MAP3K6 | 0.33683581 |
| 134 | MAPK7 | 0.33544523 |
| 135 | YES1 | 0.33521836 |
| 136 | MST1R | 0.33462199 |
| 137 | PRKAA2 | 0.33381563 |
| 138 | BMX | 0.33343061 |
| 139 | ALK | 0.32486411 |
| 140 | MKNK2 | 0.31874587 |
| 141 | EPHA3 | 0.31159917 |
| 142 | TRIB3 | 0.29580093 |
| 143 | MAP3K2 | 0.28999092 |
| 144 | BTK | 0.28466197 |
| 145 | MAPK12 | 0.27650430 |
| 146 | GRK6 | 0.26506051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.03403766 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.09979241 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.79765971 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.67093285 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.53886239 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.40493185 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.38731243 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38380220 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.27574245 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18092541 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.04821408 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.03484948 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93190460 |
| 14 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.87360076 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.85940830 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.79843395 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70877331 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69216886 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.66549941 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.63455345 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.59633890 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53529679 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.53507129 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.50205984 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.48043633 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43954086 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.40670439 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39699687 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39100339 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.38056826 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37502955 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.34434769 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.34192459 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.33856215 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.32010161 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28869388 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20462062 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18475581 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17007157 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15535567 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.11358902 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 1.11232154 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11033207 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10553983 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09880382 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.09298623 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08447566 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06094187 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05146160 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02194098 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01262320 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99823142 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99748335 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98962995 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95989303 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95215332 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92355355 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92141247 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91297373 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.88512604 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.86996376 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85147480 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.83371977 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80345646 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79685513 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79577133 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.76045250 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75976032 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.74745971 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.72818548 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70398133 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68461171 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67130824 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.66547081 |
| 75 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66252259 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66152456 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.65188038 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63751187 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63468076 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61379418 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.58133882 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57275471 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55735984 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55087096 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.53189503 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52866719 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.47277715 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46323916 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46219706 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45613582 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45161474 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43613299 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42819769 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.41837060 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41656819 |
| 96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.39733790 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38872665 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38402492 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37855871 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37256970 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37245731 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36448607 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36256035 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.35947589 |
| 105 | Homologous recombination_Homo sapiens_hsa03440 | 0.35742195 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35243691 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.35158329 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35072998 |
| 109 | DNA replication_Homo sapiens_hsa03030 | 0.35020320 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34161471 |
| 111 | Peroxisome_Homo sapiens_hsa04146 | 0.34021764 |
| 112 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33936845 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33487113 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33485699 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32709727 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.32394996 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31788117 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31312396 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31257470 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30769367 |
| 121 | Ribosome_Homo sapiens_hsa03010 | 0.30590595 |
| 122 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.30235109 |
| 123 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29902964 |
| 124 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.29745860 |
| 125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29424497 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29107729 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28610148 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28042062 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27323710 |
| 130 | Spliceosome_Homo sapiens_hsa03040 | 0.26876269 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25517107 |
| 132 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.25045789 |
| 133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.23581792 |
| 134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23082292 |
| 135 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.21519805 |

